AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal

AbbVie Inc. announced plans to raise at least $8 billion through an investment-grade bond offering to help finance its acquisition of Apogee Therapeutics Inc. The debt offering would cover part of the purchase price for the Apogee deal. AbbVie did not specify the total deal value or the complete funding structure in the announcement.

Next story